Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Actuarial Approach01:20

Actuarial Approach

384
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
384
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

792
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
792
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

712
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
712
Cancer Survival Analysis01:21

Cancer Survival Analysis

863
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
863

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Population Skin Cancer Screening and Melanoma Mortality Rates.

JAMA dermatology·2026
Same author

Ascertainment of Cancer Cases in the German National Cohort (NAKO): Methods and Initial Results.

Deutsches Arzteblatt international·2026
Same author

Supplemental Breast Ultrasound in Mammography Screening for Women with Critically Dense Breasts.

Cancers·2026
Same author

Clinical characteristics and survival of small cell lung cancer with limited or extensive synchronous metastatic spread - A German population-based cancer-registry based cohort study.

Lung cancer (Amsterdam, Netherlands)·2026
Same author

Communication-related aspects drive senior patients' satisfaction with the process of decision-making in cancer therapy.

Scientific reports·2026
Same author

Treatment of retroperitoneal sarcoma in Germany between 2000 and 2022: a retrospective analysis from the German Cancer Registry Group.

Journal of cancer research and clinical oncology·2026
Same journal

A GenAI Pipeline for Violinist Kinematic Data Management.

Studies in health technology and informatics·2026
Same journal

AMAL-For-Qatar: A Comprehensive AI Ecosystem for Fetal Ultrasound Analysis - Project Overview and Achievements.

Studies in health technology and informatics·2026
Same journal

Longitudinal Treatment-Aware Multimodal AI for Dermatology: A Scoping Review.

Studies in health technology and informatics·2026
Same journal

Predicting Postpartum Depression Using Imbalance-Aware Machine Learning.

Studies in health technology and informatics·2026
Same journal

Validation of Deep-Learning Models for Autosegmentation of Brain Metastases.

Studies in health technology and informatics·2026
Same journal

Delay-Dependent Gating in Modular RNNs.

Studies in health technology and informatics·2026
查看所有相关文章

相关实验视频

Updated: May 5, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

9.2K

肺癌存活率估计使用来自七个德国癌症登记处的数据.

Sebastian Germer1, Christiane Rudolph2, Alexander Katalinic2,3

  • 1German Research Center for Artificial Intelligence (DFKI), Lübeck.

Studies in health technology and informatics
|May 17, 2025
PubMed
概括
此摘要是机器生成的。

预测肺癌患者的生存率对于治疗评估至关重要. 根据梯度增强模型分析,诊断时的年龄和远程转移显著影响长期生存.

关键词:
可解释的人工智能肺癌 肺癌 是 一种 肺癌.生存分析的分析.

更多相关视频

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

1.0K
Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

892

相关实验视频

Last Updated: May 5, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

9.2K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

1.0K
Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

892

科学领域:

  • 在瘤学瘤学.
  • 医疗信息学 医疗信息学
  • 生物统计学 生物统计学

背景情况:

  • 准确预测癌症患者的生存率对于治疗规划和评估至关重要.
  • 肺癌的预后仍然是临床瘤学的重大挑战.
  • 利用电子健康记录和注册数据可以改善生存预测模型.

研究的目的:

  • 预测肺癌患者的短期 (6,12,18,24个月) 生存概率.
  • 使用机器学习识别影响肺癌患者生存的关键预后因素.
  • 提高瘤学中生存预测模型的可解释性.

主要方法:

  • 利用来自七个德国癌症登记处的肺癌数据.
  • 应用数据整合和预处理技术.
  • 采用渐变增强算法来预测存活率,并对模型可解释性具有重要作用的 permutation 特性.

主要成果:

  • 梯度增强模型成功预测了6,12,18和24个月的患者存活率.
  • 诊断时的年龄和远程转移的存在被确定为对长期生存最有影响的特征.
  • 变换特征的重要性为模型的决策过程提供了洞察力.

结论:

  • 机器学习模型,特别是梯度增强,可以有效预测肺癌存活率.
  • 年龄和转移状态是肺癌患者长期生存的关键决定因素.
  • 鉴定的预后因素可以为未来的多变量生存分析和临床决策提供信息.